Table 3 Comparisons of surgical outcomes and postoperative clinical characteristics between two groups.
Variables, mean ± SD or n (%) | FV-UAS group (n = 75) | MPCNL group (n = 74) | t/χ2 value | P value |
|---|---|---|---|---|
Immediately SFR | 59 (78.7) | 60 (81.1) | 0.135 | 0.713 |
Total SFR | 67 (89.3) | 65 (87.8) | 0.082 | 0.774 |
Lithotripsy time, min | 113.1 ± 6.7 | 82.5 ± 5.4 | 30.670 | < 0.001** |
Hemoglobin decrease, g/L | 8.2 ± 3.3 | 17.7 ± 2.9 | − 18.656 | < 0.001** |
Postoperative hospital stays, days | 1.7 ± 0.6 | 3.1 ± 0.5 | − 15.462 | < 0.001** |
Balloon dilatation | 8 (10.7) | – | – | – |
Required second access tracts | – | 23 (31.1) | – | – |
Qol score improvement | 33.4 ± 6.5 | 26.9 ± 7.1 | 5.830 | < 0.001** |
3 months ureteral stricture | 1 (1.3) | 3 (4.1) | 1.055 | 0.304 |
Clavien-Dindo | 5.655 | 0.017* | ||
Grade Ⅰ-Ⅱ | 7 (9.3) | 16 (21.6) | – | – |
Grade Ⅲ-Ⅳ | 1 (1.3) | 3 (4.1) | – | – |
Complications | ||||
Fever (> 38.5℃) (Clavien grade Ⅰ) | 5 (6.7) | 9 (12.2) | 1.337 | 0.247 |
Low back pain (Clavien grade Ⅰ) | 4 (5.2) | 13 (17.6) | 5.516 | 0.019* |
Perirenal hematoma (Clavien grade Ⅱ) | 2 (2.6) | 11 (14.9) | 6.959 | 0.008** |
Blood transfusion (Clavien grade Ⅱ) | 0 (0.0) | 2 (2.7) | 2.055 | 0.152 |
Urosepsis (Clavien grade Ⅳ) | 1 (1.3) | 3 (4.1) | 1.055 | 0.304 |
Stone compositions | 2.096 | 0.553 | ||
Calcium oxalate | 44 (60.0) | 42 (54.3) | – | – |
Calcium phosphate | 13 (6.3) | 8 (6.4) | – | – |
Struvite or carbonated apatite | 11 (24.2) | 15 (27.6) | – | – |
Uric acid or cysteine | 7 (9.5) | 9 (11.7) | – | – |